WHO ICTRP trial
Chemoradiation therapy on conversion surgery for unresectable locally advanced…
JPRN-jRCTs051210167 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCTs051210167 |
|---|---|
| Public title | Chemoradiation therapy on conversion surgery for unresectable locally advanced pancreatic cancer |
| Scientific title | The survival benefit of chemoradiation (Gem/nab-PTX+RT) followed by conversion surgery in patients with unresectable locally advanced pancreatic cancer: multicenter randomized phase II trial |
| Primary sponsor | Kobayashi Shogo |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Conditions | Pancreatic ductal adenocarcinoma Unresectable locally advenced pancreatic cancer, Prospective randomized control study, Chemoradiotherapy, Conversion surgery;D021441;Unresectable locally advenced pancreatic cancer, Prospective randomized… |
| Interventions | Group suegery surgery Group Post-chemotherapy surgery GEM;800mg/m2,intravenous infusion on Day1,Da y8,Day15,Day29 nab-PTX;100mg,intravenous infusion on Day1,Da y8,Day15,Day29 RT;2.0 Gy/day,from Monday to Friday every week, total 50.0 Gy… |
| Registration date | Mar 2, 2022 |
| Target size | 70 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: